<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03391323</url>
  </required_header>
  <id_info>
    <org_study_id>SJRC-GMK</org_study_id>
    <nct_id>NCT03391323</nct_id>
  </id_info>
  <brief_title>Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study</brief_title>
  <official_title>Medacta GMK Sphere® Medial-Pivot, Cruciate Substituting vs. Medacta GMK PS Posterior Stabilized Kne vs. OMNI Apex Knee Ultracongruent vs. Triathlon® Posterior Stabilized &amp; Cruciate Substituting Outcomes Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>David F. Scott, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medacta USA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Spokane Joint Replacement Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective, randomized comparison of total knee arthroplasty with the Medacta
      GMK Sphere® knee compared to the Medacta GMK PS knee, with comparison to data from previous
      trials of similar study design.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forgotten Joint Score (FJS)</measure>
    <time_frame>Change from baseline at 2 years and 5 years post-operative</time_frame>
    <description>The average Forgotten Joint Score (FJS) of those patients receiving the Medacta GMK Sphere® knee prosthesis will be compared with the average FJS of those receiving the Medacta GMK PS knee prosthesis.
The FJS total score range is 0-100, with higher scores indicating a higher degree of &quot;forgetting&quot; the artificial joint, that is, a lower degree of awareness.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Knee Society Score (KSS)</measure>
    <time_frame>Pre-operative, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative</time_frame>
    <description>Clinical outcomes will be evaluated via the Knee Society Score (KSS). The KSS is subdivided into a Knee Assessment score which rates only the knee joint itself, and a Functional Assessment score which rates the subject's ability to walk and climb stairs. Both scores range from 0-100, with a higher score indicating a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower Extremity Activity Scale (LEAS)</measure>
    <time_frame>Pre-operative, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative</time_frame>
    <description>Clinical outcomes will be evaluated via the Lower Extremity Activity Scale (LEAS). The LEAS scale range is 1-18, with a higher value indicating a higher level of activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Analysis</measure>
    <time_frame>Pre-operative, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative</time_frame>
    <description>Radiographs will be assessed for radiolucency, migration and subsidence. An AP Longstanding view will be obtained pre-operatively, and at 6 weeks and 1 year post-operatively to determine degree of Varus or Valgus.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Joint Disease</condition>
  <arm_group>
    <arm_group_label>Medacta GMK Sphere® Medial-Pivot Knee Prosthesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Medacta GMK PS Posterior Stabilized Knee Prosthesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta GMK Sphere® Medial-Pivot Knee Prosthesis</intervention_name>
    <arm_group_label>Medacta GMK Sphere® Medial-Pivot Knee Prosthesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta GMK PS Posterior Stabilized Knee Prosthesis</intervention_name>
    <arm_group_label>Medacta GMK PS Posterior Stabilized Knee Prosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients willing to sign the Informed Consent.

          -  Patients able to comply with follow-up requirements including postoperative weight
             bearing restrictions and self-evaluations.

          -  Male and non-pregnant female patients ages 21 - 80 years of age at the time of
             surgery.

          -  Patients requiring a primary total knee replacement.

          -  Patients with a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or
             avascular necrosis (AVN).

          -  Patients with intact collateral ligaments.

        Exclusion Criteria:

          -  Patients with inflammatory arthritis.

          -  Patients that are morbidly obese, body mass index (BMI) &gt; 40.

          -  Patients with a history of total or unicompartmental reconstruction of the affected
             joint.

          -  Patients with neuromuscular or neurosensory deficiency, which would limit the ability
             to assess the performance of the device.

          -  Patients with a systemic or metabolic disorder leading to progressive bone
             deterioration.

          -  Patients that are immunologically compromised, or receiving chronic steroids (&gt;30
             days), excluding inhalers.

          -  Patients bone stock is compromised by disease or infection, which cannot provide
             adequate support and/or fixation to the prosthesis.

          -  Patients with knee fusion to the affected joint.

          -  Patients with an active or suspected latent infection in or about the knee joint.

          -  Patients whose surgery will utilize computer-assisted surgical navigation (CAOS)
             techniques.

          -  Patients whose surgery will utilize minimally invasive surgical techniques.

          -  Patients that are prisoners.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Scott, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spokane Joint Replacement Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Scott, MD</last_name>
    <phone>509-466-6393</phone>
    <email>dfscott@mac.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Spokane Joint Replacement Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Scott, MD</last_name>
      <phone>509-466-6393</phone>
      <email>dfscott@mac.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2017</study_first_submitted>
  <study_first_submitted_qc>December 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2018</study_first_posted>
  <last_update_submitted>December 29, 2017</last_update_submitted>
  <last_update_submitted_qc>December 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Spokane Joint Replacement Center</investigator_affiliation>
    <investigator_full_name>David F. Scott, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

